Roche · 1 day ago
2026 Summer Intern - Discovery Oncology
Roche is a leading biotechnology company, and they are seeking a summer intern for their Discovery Oncology department. The intern will participate in biology research focused on oncology targets, utilizing molecular biology and high content imaging techniques.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Work together with other scientists in the group to design and execute experiments using cell culture and confocal microscopy imaging techniques
Keep detailed records of the research findings using an electronic notebook
Communicate and present results to a diverse group of scientists during internal meetings
Qualification
Required
Must be pursuing a PhD (enrolled student)
Required Majors: Molecular Biology, Cell Biology, Cancer Biology, Biochemistry, or related field
Hands-on research experience in cell biology/biochemistry/molecular biology lab environment is required
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Experience in advanced cell culture techniques such as RNAi, cell line engineering using CRISPR/Cas9 or PiggyBac transposase systems
Interest in biomolecular condensates, intrinsically disordered proteins, chromatin and transcriptional regulation
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Recent News
Pharmaceutical Technology
2026-01-13
2026-01-12
Company data provided by crunchbase